Td Waterhouse Canada Inc. Laboratory Corp Of America Holdings Transaction History

Td Waterhouse Canada Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$209.01 - $232.56 $2,926 - $3,255	14 Added 2.55%	564 $120 Million
Q4 2023 Feb 12, 2024	BUY	$197.69 - $227.29 $59,307 - $68,187	300 Added 120.0%	550 $124 Million
Q3 2023 Nov 13, 2023	BUY	$201.05 - $221.7 $17,491 - $19,287	87 Added 53.37%	250 $49.9 Million
Q2 2023 Nov 13, 2023	BUY	$211.93 - $241.33 $2,755 - $3,137	13 Added 8.67%	163 $34 Million
Q4 2022 Nov 13, 2023	SELL	$203.72 - $248.97 $268,095 - $327,644	-1,316 Reduced 89.77%	150 $35.7 Million
Q3 2022 Nov 13, 2023	BUY	$204.81 - $262.19 $36,046 - $46,145	176 Added 13.64%	1,466 $411 Million
Q2 2022 Nov 13, 2023	BUY	$213.86 - $277.87 $258,770 - $336,222	1,210 Added 1512.5%	1,290 $394 Million
Q1 2022 Nov 13, 2023	BUY	$259.82 - $298.18 $20,785 - $23,854	80 New	80 $21.1 Million

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20.6B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Td Waterhouse Canada Inc., based on Form 13F filings with the SEC.

Stay updated on Td Waterhouse Canada Inc. with notifications on news.